Literature DB >> 14580655

Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.

Robert H Fryer1, Richard C Anderson, Claudia A Chiriboga, Neil A Feldstein.   

Abstract

Moyamoya disease is a relatively uncommon neurovascular complication of sickle cell anemia. We report a case series of six patients with sickle cell anemia who developed moyamoya disease and underwent encephaloduroarteriosynangiosis procedures. These six patients presented with either cerebrovascular accidents, transient ischemic attacks, or seizures, and subsequent magnetic resonance imaging scans were suggestive of moyamoya-like changes in the cerebral vasculature. Conventional cerebral angiography was used to confirm the diagnosis in all six patients. Four of six patients manifested a cerebrovascular accident before surgery, and two of these patients were compliant on a transfusion protocol at the time of their cerebrovascular accident. Bilateral (n = 4) or unilateral (n = 2) encephaloduroarteriosynangiosis procedures were performed without any complications. The patient who was stroke-free preoperatively had a cerebrovascular accident 2 weeks after the procedure; otherwise, all patients have remained free of neurovascular complications with an average follow-up of 33 months. Collateral anastomoses between external and internal carotid arteries were established by magnetic resonance angiography in three patients. The encephaloduroarteriosynangiosis procedure is a safe and effective treatment option in patients with sickle cell anemia who develop moyamoya disease.

Entities:  

Mesh:

Year:  2003        PMID: 14580655     DOI: 10.1016/s0887-8994(03)00047-x

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  10 in total

Review 1.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

2.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.

Authors:  Erin M Hall; Jeffrey Leonard; Jodi L Smith; Kristin P Guilliams; Michael Binkley; Robert J Fallon; Monica L Hulbert
Journal:  Pediatr Blood Cancer       Date:  2016-04-22       Impact factor: 3.167

4.  Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results.

Authors:  Margaret T Lee; Sergio Piomelli; Suzanne Granger; Scott T Miller; Shannon Harkness; Donald J Brambilla; Robert J Adams
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

5.  Stroke in Children with Sickle Cell Disease.

Authors:  Fenella J. Kirkham; Michael R. DeBaun
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

6.  Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.

Authors:  Nadeem I Khan; Ali A Saherwala; Mo Chen; Sepand Salehian; Hisham Salahuddin; Babu G Welch; Marco C Pinho; Ty Shang
Journal:  Cerebrovasc Dis Extra       Date:  2019-12-12

7.  Surgical revascularisation for childhood moyamoya.

Authors:  J Ng; D Thompson; J P S Lumley; D E Saunders; V Ganesan
Journal:  Childs Nerv Syst       Date:  2012-05-09       Impact factor: 1.475

8.  Ischemic infarction following an intra-cerebral hemorrhage in an adult sickle cell disease with angiographic Moyamoya.

Authors:  Praveen Kumar Gupta; Krishnan Pudukode Ramnath; Prabha Ramadorai; Abdulla Alajmi; Janaki Sudhakar Praharaju
Journal:  J Thromb Thrombolysis       Date:  2007-06-01       Impact factor: 2.300

9.  Mood and Stress Evaluation of Adult Patients With Moyamoya Disease in Korea: Ecological Momentary Assessment Method Using a Mobile Phone App.

Authors:  Kyu Won Shim; Mona Choi; Yong Sook Yang; Gi Wook Ryu; Chang Gi Park; Insun Yeom
Journal:  JMIR Mhealth Uhealth       Date:  2020-05-25       Impact factor: 4.773

10.  American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

Authors:  M R DeBaun; L C Jordan; A A King; J Schatz; E Vichinsky; C K Fox; R C McKinstry; P Telfer; M A Kraut; L Daraz; F J Kirkham; M H Murad
Journal:  Blood Adv       Date:  2020-04-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.